Your position:
m.limatoxi.com
>>
EN
>>
EN
>>
Formulation
>>
Dapagliflozin is approved in the EU for the treatment of symptomatic chronic heart failure
>> article
Dapagliflozin is approved in the EU for the treatment of symptomatic chronic heart failure
Editor:xuezhe Clicks:
0
Date:2023-2-16 13:54:25
Keyword:
Dapagliflozin
Healthoo Information:
Dapagliflozin is approved in the EU for the treatment of symptomatic chronic heart failure
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
Dapagliflozin is approved in the EU for the treatment of symptomatic c...
Linkai to build Dapagliflozin etc. APIs project
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
map
